Arcellx (ACLX) Income from Continuing Operations (2021 - 2025)

Arcellx's quarterly Income from Continuing Operations came in at 58112000.0 in Q4 2025, down 23.43% year-on-year from 75893788.4 in Q4 2024, and down 4.18% quarter-over-quarter from 55781000.0 in Q3 2025.

Arcellx has reported Income from Continuing Operations for 5 years, with the latest figure at 58112000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Income from Continuing Operations fell 23.43% year-over-year to 58112000.0; the trailing twelve-month figure through Dec 2025 stood at 228934000.0 (down 113.39% YoY), and the FY2025 full-year result was 228934000.0, down 113.26% from the prior year.
  • Income from Continuing Operations for Q4 2025 stood at 58112000.0, down from 55781000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 19844000.0 in Q4 2023, with the low at 92874000.0 in Q3 2022.
  • Average Income from Continuing Operations over 5 years is 33030250.0, with a median of 27252500.0 recorded in 2023.
  • Year-over-year, Income from Continuing Operations surged 150.89% in 2023 and tumbled 765.1% in 2025.
  • Tracing ACLX's Income from Continuing Operations over 5 years: stood at 20698000.0 in 2021, then tumbled by 88.39% to 38992000.0 in 2022, then surged by 150.89% to 19844000.0 in 2023, then slumped by 337.26% to 47081000.0 in 2024, then retreated by 23.43% to 58112000.0 in 2025.
  • The last three Income from Continuing Operations figures came in at 58112000.0 (Q4 2025), 55781000.0 (Q3 2025), and 52771000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -2.99 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -8.40 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -14.46 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.03 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -3.40 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 727.20 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 205.99 Mn
10 Arcellx 6.48 Bn 6.48 Bn - -58.11 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -58.11 Mn
Sep 30, 2025 -55.78 Mn
Jun 30, 2025 -52.77 Mn
Mar 31, 2025 -62.27 Mn
Dec 31, 2024 -47.08 Mn
Sep 30, 2024 -25.84 Mn
Jun 30, 2024 -27.16 Mn
Mar 31, 2024 -7.20 Mn
Dec 31, 2023 19.84 Mn
Sep 30, 2023 -39.34 Mn
Jun 30, 2023 -23.85 Mn
Mar 31, 2023 -27.34 Mn
Dec 31, 2022 -38.99 Mn
Sep 30, 2022 -92.87 Mn
Jun 30, 2022 -30.77 Mn
Mar 31, 2022 -26.04 Mn
Dec 31, 2021 -20.70 Mn
Sep 30, 2021 -17.11 Mn
Jun 30, 2021 -15.93 Mn
Mar 31, 2021 -11.28 Mn